Acta Cryst. (2006). E62, m1660-m1662  [ doi:10.1107/S1600536806024081 ]

Bromotricarbonyl{15-[2-(methylsulfanyl)ethylsulfanyl]pentadecanoic acid-²S,S'}rhenium(I)

W. Kraus, M. Walther, C. M. Jung, F. Emmerling and H.-J. Pietzsch

Abstract: The title compound, [ReBr(C₁₈H₃₆O₂S₂)(CO)₃], was synthesized and characterized as a non-radioactive surrogate of a novel Tc-containing fatty acid derivative prepared according to the tricarbonyl/dithioether design with the objective of developing new Tc-based radiopharmaceuticals for the non-invasive diagnosis of myocardial metabolism. The Re chelate contains the metal in the oxidation state +1 and is attached to the terminal position of a fatty acid. The complex formation was accomplished by a ligand exchange reaction using [NBu₄]₂[Re(CO)₃Br₃] as starting material.

Online 28 June 2006

Copyright © International Union of Crystallography
IUCr Webmaster